Zofran® Birth Defects
Zofran® (ondansetron) is approved by the U.S. Food and Drug Administration (FDA) to treat nausea and vomiting caused by cancer treatments and surgery. But the drug is also prescribed to treat patients suffering from a variety of off-label—or unapproved—uses, including severe morning sickness in pregnant women. But FDA data indicates that babies born to mothers who take Zofran while pregnant may be at risk of severe birth defects.
If you took Zofran to treat morning sickness and your child was born with birth defects, you may be entitled to compensation. Our drug injury lawyers want to help stop the harm caused by pharmaceutical company negligence, and we’re here to fight for your family’s rights. Contact our legal team now, and let us help you get started with your claim today.
Zofran® Birth Injury Risks
Developing fetuses are most vulnerable during the first trimester of pregnancy—when morning sickness is most common among expectant mothers. But data in the FDA’s Adverse Event Reporting System, a database of drug side effects and medication errors, indicates that using Zofran while pregnant may lead to certain birth defects, such as:
- Cleft lip
- Cleft palate
- Heart defects
- Kidney issues
GlaxoSmithKline, the drug company that produces Zofran, has stated that the fetal injury risks posed by ondansetron are not yet known. However, the company paid a $3 billion settlement in 2012 after the U.S. Department of Justice determined it was promoting Zofran, along with several other drugs, for off-label uses.
Get Started With Your Zofran® Lawsuit
Our law firm has experience helping injury victims and their families get through some of the most difficult times of their lives, and we’re here to help you too. Our legal team has the knowledge and resources to investigate your claim and fight for the compensation you need for your child’s medical bills, pain and suffering, and future care.
Your time to file a Zofran birth injury claim is limited—so don’t wait. Call or contact us online to get started now.
Zofran® is a registered trademark of Glaxo Group Limited Corporation and is used here only to identify the product in question. This law firm is not affiliated with, sponsored by, or associated with Glaxo Group Limited Corporation; the U.S. Department of Justice; or the U.S. Food and Drug Administration.